Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis

ClinicalTrials.gov ID: NCT01116427

Public ClinicalTrials.gov record NCT01116427. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Abatacept in Adults With Relapsing-remitting Multiple Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The ACCLAIM study is testing whether the medication "abatacept" can be of benefit to patients with relapsing-remitting multiple sclerosis (MS). Although abatacept is an investigational medication for MS, it is not a new drug. Abatacept has been approved by the FDA to treat rheumatoid arthritis.

Study identification

NCT ID
NCT01116427
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
65 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Feb 2015 (Actual)
Last update posted
Sep 15, 2016

2010 – 2015

United States locations

U.S. sites
20
U.S. states
17
U.S. cities
20
Facility City State ZIP Site status
St. Josephs Hospital and Medical Center - Barrow Neurology Phonix Arizona 85013 —
Jordan Research and Education Institute (REDI): Alta Bates Summit Medical Center Berkeley California 94705 —
University of Southern California - Keck School of Medicine Los Angeles California 90033 —
Newport Beach Clinical Research Associates, Inc. Newport Beach California 92663 —
University of California, Davis Sacramento California 95817 —
University of Miami Miami Florida 33136 —
South Suburban Neurology Flossmoor Illinois 60422 —
Norton Neuroscience Institute - Norton Neurology Services MS Center Louisville Kentucky 40207 —
Louisiana State University Shreveport Louisiana 71130 —
University of Maryland Baltimore Maryland 21201 —
Brigham & Women's Hospital Boston Massachusetts 02115 —
University of Minnesota Minneapolis Minnesota 55414 —
Judith Jaffe Multiple Sclerosis Center: Weill Cornell Medical College New York New York 10065 —
University of North Carolina Chapel Hill North Carolina 27514 —
Neurology Specialists, Inc. Dayton Ohio 45417 —
Providence St. Vincent Medical Center Portland Oregon 97225 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
The Neurology Foundation, Inc. Providence Rhode Island 02905 —
Advanced Neurosciences Institute Franklin Tennessee 37064 —
Benaroya Research Institute at Virginia Mason Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01116427, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2016 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01116427 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →